Summary

Introduction to Asia-Pacific Liquid Biopsy Market

The Asia-Pacific liquid biopsy market was valued at $708.1 million in 2024 and is expected to reach $2,927.3 million by 2033, growing at a CAGR of 17.08% during the forecast period 2024-2033. Liquid biopsies are becoming a revolutionary non-invasive diagnostic tool for cancer detection and monitoring in APAC. This novel approach provides real-time monitoring with minimal invasiveness, assesses treatment responses, and has the potential to detect early cancer recurrence detection. There is a greater need for liquid biopsy tests and products as a result of the market's expansion due to the rising prevalence of cancer, rising research publications, and growing clinical trials. More innovative and efficient tests have been developed quickly as a result of the growing preference for minimally invasive diagnostic techniques.

Additionally, the market has grown more quickly as a result of government initiatives that have been implemented to improve cancer detection and treatment management. Many distribution channels, including online platforms and retail outlets, have made liquid biopsy products enhancing accessibility and ensuring broader consumer reach across the region. These factors, along with increasing patient demand for non-invasive cancer screening, are helping the APAC liquid biopsy market gain significant momentum, paving the way for more efficient and accessible cancer detection solutions across the region.

Market Introduction

The APAC Liquid Biopsy Market is expanding quickly as a non-invasive alternative for cancer monitoring and detection, providing a number of benefits over conventional biopsy techniques. With the least amount of discomfort to the patient, liquid biopsy enables early cancer detection, real-time monitoring, and evaluation of treatment responses by examining circulating tumor DNA (ctDNA), RNA, and exosomes from blood samples. Because of the rising incidence of cancer in the area and the need for personalized medicine and minimally invasive diagnostic solutions, this technology is becoming more and more popular.

Rising cancer rates, technological developments in biomarker detection, and the expansion of applications beyond oncology, such as in cardiology and infectious diseases, are the main factors propelling the market's growth. Government initiatives, rising research funding, and a change in priorities are all contributing to the increasing use of liquid biopsy toward precision medicine. The growing adoption of liquid biopsy is supported by government initiatives, increasing research funding, and a shift toward precision medicine. Moreover, the increasing availability of liquid biopsy tests through online platforms and healthcare providers is enhancing accessibility, driving market adoption across APAC, and improving patient outcomes through earlier diagnosis and better treatment monitoring.

Market Segmentation:

Segmentation 1: by End User
• Academic and Research Institutions
• Clinical Laboratories
• Pharmaceutical and Biotechnology
• Companies
• Other End Users

Segmentation 2: by Region
• Asia-Pacific
o Japan
o India
o China
o South Korea
o Australia
o Singapore
o Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific liquid biopsy market has been segmented based on various categories, such as end user and country.

Competitive Strategy: The Asia-Pacific liquid biopsy market is highly fragmented, with many smaller and private companies constantly entering the market. Key players in the liquid biopsy market analyzed and profiled in the study involve established players that offer various kinds of products and services.

ページTOPに戻る

Table of Contents

Executive Summary
Scope and Definition
1 Market
1.1 Market Trends
1.1.1 Increasing Product Launches in the Market
1.1.2 Growing Funding by the Key Players in the Market
1.2 Supply Chain Analysis: Asia-Pacific Liquid Biopsy Market
1.3 Regulatory Framework
1.3.1 Regulation in Other Countries
1.4 COVID-19 Impact on Asia-Pacific Liquid Biopsy Market
1.5 Recently Launched Product/Services
1.6 Reimbursement Scenario
1.7 Financing Scenario
1.7.1 Key Players Patent Portfolio
1.7.2 Key Players Stratification as per Raised Financing Value
1.7.3 Key Players Financing Analysis (by Company)
1.8 Product Mapping Analysis
1.8.1 By Technology
1.8.2 By Sample
1.8.3 By Circulating Biomarker
1.8.4 By Clinical Application
1.9 Total Addressable Market and Penetration
1.1 Liquid Biopsy Market: Stakeholder Analysis (N=30)
1.10.1 Physicians’ Perception
1.10.2 Payer’s Perception
1.10.3 Investors’ Perception
1.11 Liquid Biopsy Government Initiatives
1.12 Market Dynamics Overview
1.12.1 Market Drivers
1.12.1.1 Rising Burden of Cancer
1.12.1.2 Growing Research Publications and Clinical Trials in Liquid Biopsy
1.12.1.3 Growing Adoption and Demand of Minimally Invasive Cancer Detection Methods
1.12.2 Market Restraints
1.12.2.1 Technical Limitations in Liquid Biopsy
1.12.2.2 Uncertain Reimbursement and Recommendations for Liquid Biopsy Tests
1.12.3 Market Opportunities
1.12.3.1 Integration of AI in Liquid Biopsy
1.12.3.2 Use of Liquid Biopsy for Precision Medicine in Oncology
2 Regions
2.1 Asia-Pacific
2.1.1 Regional Overview
2.1.2 Driving Factors for Market Growth
2.1.3 Factors Challenging the Market
2.1.4 Test Volume
2.1.5 Market Size and Forecast
2.1.5.1 By End User
2.1.6 China
2.1.6.1 Test Volume
2.1.6.2 Market Size and Forecast
2.1.6.2.1 By End User
2.1.7 Japan
2.1.7.1 Test Volume
2.1.7.2 Market Size and Forecast
2.1.7.2.1 By End User
2.1.8 India
2.1.8.1 Test Volume
2.1.8.2 Market Size and Forecast
2.1.8.2.1 By End User
2.1.9 Australia
2.1.9.1 Test Volume
2.1.9.2 Market Size and Forecast
2.1.9.2.1 By End User
2.1.10 South Korea
2.1.10.1 Test Volume
2.1.10.2 Market Size and Forecast
2.1.10.2.1 By End User
2.1.11 Singapore
2.1.11.1 Test Volume
2.1.11.2 Market Size and Forecast
2.1.11.2.1 By End User
2.1.12 Rest-of-Asia-Pacific
2.1.12.1 Test Volume
2.1.12.2 Market Size and Forecast
2.1.12.2.1 By End User
3 Markets - Competitive Benchmarking & Company Profiles
3.1 Company Profiles
3.1.1 Sysmex Corporation
3.1.1.1 Overview
3.1.1.2 Top Products
3.1.1.3 Top Competitors
3.1.1.4 Key Personnel
3.1.1.5 Analyst View
4 Research Methodology
4.1 Data Sources
4.1.1 Primary Data Sources
4.1.2 Secondary Data Sources
4.1.3 Data Triangulation
4.2 Market Estimation and Forecast
List of Figures
Figure 1: Asia-Pacific Liquid Biopsy Market, $Million, 2024, 2028, and 2033
Figure 2: Key Events to Keep Track of in the Liquid Biopsy Market
Figure 3: Impact of COVID-19 on Liquid Biopsy Market
Figure 4: Patent Published (by Country), January 2021-May 2024
Figure 5: Number of Liquid Biopsy Patents (by Year), January 2021-May 2024
Figure 6: Financing Analysis (by Latest Deal Amount), $Million, FY2023-2024
Figure 7: Asia-Pacific Liquid Biopsy Market Scenario, 2023
Figure 8: Frequently Used Technology in Liquid Biopsy
Figure 9: Most Important Factors for Adoption of NGS-Based Liquid Biopsy
Figure 10: Treatment Guidelines for Treatment of Cancer Patients
Figure 11: Major Challenges Faced While Performing Liquid Biopsy
Figure 12: Average Cost of Technologies for the Liquid Biopsy Market (N=30 )
Figure 13: Cost Difference Across Different End Users for the Liquid Biopsy Market
Figure 14: Key Factors for Determining Reimbursement Possibility for the Liquid Biopsy Market
Figure 15: Estimated Cancer Incidence in 2020 and 2040
Figure 16: Estimated New Cancer Cases (2022-2045): Both Sexes, Ages 0-85
Figure 17: Upsurge in Research Publications in Liquid Biopsy, 2015-2023
Figure 18: Comparison of Liquid Biopsy vs. Tissue Biopsy
Figure 19: Asia-Pacific Liquid Biopsy Market, Test Volume, Thousand, 2023-2033
Figure 20: Asia-Pacific Liquid Biopsy Market, $Million, 2023-2033
Figure 21: China Liquid Biopsy Market, Test Volume, Thousand, 2023-2033
Figure 22: China Liquid Biopsy Market, $Million, 2023-2033
Figure 23: Japan Liquid Biopsy Market, Test Volume, Thousand, 2023-2033
Figure 24: Japan Liquid Biopsy Market, $Million, 2023-2033
Figure 25: India Liquid Biopsy Market, Test Volume, Thousand, 2023-2033
Figure 26: India Liquid Biopsy Market, $Million, 2023-2033
Figure 27: Australia Liquid Biopsy Market, Test Volume, Thousand, 2023-2033
Figure 28: Australia Liquid Biopsy Market, $Million, 2023-2033
Figure 29: South Korea Liquid Biopsy Market, Test Volume, Thousand, 2023-2033
Figure 30: South Korea Liquid Biopsy Market, $Million, 2023-2033
Figure 31: Singapore Liquid Biopsy Market, Test Volume, Thousand, 2023-2033
Figure 32: Singapore Liquid Biopsy Market, $Million, 2023-2033
Figure 33: Rest-of-Asia-Pacific Liquid Biopsy Market, Test Volume, Thousand, 2023-2033
Figure 34: Rest-of-Asia-Pacific Liquid Biopsy Market, $Million, 2023-2033
Figure 35: Data Triangulation
Figure 36: Top-Down and Bottom-Up Approach
Figure 37: Assumptions and Limitations
List of Tables
Table 1: Market Snapshot
Table 2: Asia-Pacific Liquid Biopsy Market, Market Opportunities
Table 3: Product Launches, January 2021-April 2024
Table 4: Some of the Strategic Funding, January 2022-April 2024
Table 5: Launched Liquid Biopsy Tests from Players in the Liquid Biopsy Market
Table 6: Reimbursement Scenario for Key Players' Offerings in the Liquid Biopsy Market
Table 7: Liquid Biopsy Market: Key Players Patent Portfolio
Table 8: Liquid Biopsy Product Mapping Analysis (by Technology)
Table 9: Liquid Biopsy Product Mapping Analysis (by Sample)
Table 10: Liquid Biopsy Product Mapping Analysis (by Circulating Biomarker)
Table 11: Liquid Biopsy Product Mapping Analysis (by Clinical Application)
Table 12: Government Initiatives for Liquid Biopsies
Table 13: Impact Analysis of Market Navigating Factors, 2023-2033
Table 14: Liquid Biopsy Market (by Region), $Million, 2023-2033
Table 15: Asia-Pacific Liquid Biopsy Market (by End User), $Million, 2023-2033
Table 16: China Liquid Biopsy Market (by End User), $Million, 2023-2033
Table 17: Japan Liquid Biopsy Market (by End User), $Million, 2023-2033
Table 18: India Liquid Biopsy Market (by End User), $Million, 2023-2033
Table 19: Australia Liquid Biopsy Market (by End User), $Million, 2023-2033
Table 20: South Korea Liquid Biopsy Market (by End User), $Million, 2023-2033
Table 21: Singapore Liquid Biopsy Market (by End User), $Million, 2023-2033
Table 22: Rest-of-Asia-Pacific Liquid Biopsy Market (by End User), $Million, 2023-2033

Press Release